United States · Venture startup

Who invested in Amagma Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.3Mraised across 1 round since 2022, from 1 source

Latest round
Venture, $2.3MJun 2022
Investors
1
See who backed them

The rounds

  1. Jun 2022
    Venture$2.3M

    Source recorded

Everyone who backed them

Polaris PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Amagma Therapeutics

Who invested in Amagma Therapeutics?

Amagma Therapeutics's investors include Polaris Partners.

How much has Amagma Therapeutics raised?

Amagma Therapeutics has raised $2.3M across 1 round since 2022.

When did Amagma Therapeutics last raise?

Amagma Therapeutics's most recent round was a Venture of $2.3M in Jun 2022.

What was Amagma Therapeutics's biggest round?

Its most recent round, $2.3M in Jun 2022, is also its largest on record.

Who backed Amagma Therapeutics first?

Amagma Therapeutics's first round on record, in Jun 2022, was backed by Polaris Partners.

What stage is Amagma Therapeutics at?

Amagma Therapeutics's latest named round is a Venture, in Jun 2022.

Where is Amagma Therapeutics based?

Amagma Therapeutics is based in the United States.

Companies like Amagma Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.